Nateglinide (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Nateglinide drug offered from Cadila Healthcare Limited. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
| NON-PROPRIETARY NAME: | Nateglinide |
| SUBSTANCE NAME: | NATEGLINIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-10-27 |
| END MARKETING DATE: | 0000-00-00 |
Nateglinide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nateglinide from Cadila Healthcare Limited |
| LABELER NAME: | Cadila Healthcare Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 60(mg/1) |
| START MARKETING DATE: | 2016-10-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70771-1015_c06899f5-2a30-4c30-8596-0746e226f927 |
| PRODUCT NDC: | 70771-1015 |
| APPLICATION NUMBER: | ANDA205248 |
Other NATEGLINIDE Pharmaceutical Manufacturers / Labelers:
